Tulyp Medical, a Paris-based startup developing a medical device for intelligent pressure-driven perfusion, emerged from ...
In patients with sepsis, the use of a noninvasive light-based treatment significantly improves key metabolic biomarkers from ...
The U.S. Food and Drug Administration (FDA) has granted Vascular Perfusion Solutions, Inc. (VPS) a Breakthrough Device Designation for its groundbreaking VP.S Encore™ oxygenated perfusion cardiac ...
The New York University School of Medicine and collaborators found that capillary-associated macrophages in skin decline with ...
MedPage Today on MSN
STEMI Outcomes Not Helped by Upfront Instantaneous Wave-Free Ratio, Multivessel PCI
Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex ...
The research team led by Professors Young Eun Jang and Jung Bin Park from the Department of Anesthesiology and Pain Medicine ...
SAN ANTONIO--(BUSINESS WIRE)--Vascular Perfusion Solutions, Inc. (VPS) has received its first donated human heart for research through a partnership with Texas Organ Sharing Alliance (TOSA). VPS is ...
Findings published in Biological Psychiatry point to new therapeutic pathways to protect this at-risk population from heart failure and improve life expectancy Despite accumulating evidence that ...
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. The research uncovered ...
Company unveils patented technology designed to help maintain healthy blood flow during vascular procedures Backed by Sofinnova MD Start and led by experienced medtech entrepreneurs and cardiologists ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback